RE:RE:RE:Summary of Results for Newbiesmenoalittle wrote
]after reviewing a few summaries posted here of results this far, it appears there was mention made of none of the participants having received a second treatment... which I don't think is totally accurate.
furthermore, there was no mention of the treatment(s) durability.
now, I know there was news of the 2 from phase 2 being CR at 450 days. and, unless I'm mistaken... I seem to recall reading somewhere (probably a post on this board) that there might be 4 that are CR at 450 days. I haven't had time to verify what the truth here actually is.
Would someone that has the scope on it be so kind as to clarify this for me? TIA It was from the recent newsletter menoalittle 4 patients at 360 & 450 days.
Assessment Day* | 90 Days | 180 Days | 270 Days | 360 Days | 450 Days |
# | % | # | % | # | % | # | % | # | % |
Complete Response (“CR”) | 14 | 42 | % | 7 | 21 | % | 7 | 21 | % | 4 | 12 | % | 4 | 12 | % |
Partial Response (“PR”) | 4 | 12 | % | 5 | 15 | % | 2 | 6 | % | 4 | 12 | % | 2 | 6 | % |
Pending | 7 | 21 | % | 13 | 39 | % | 15 | 45 | % | 16 | 48 | % | 17 | 52 | % |
No Response (“NR”) | 8 | 24 | % | 8 | 24 | % | 9 | 27 | % | 9 | 27 | % | 10 | 30 | % |
Total Treated* | 33 | 100 | % | 33 | 100 | % | 33 | 100 | % | 33 | 100 | % | 33 | 100 | % |
*Includes three (3) patients treated at the Therapeutic Dose form Phase Ib NMIBC Clinical Study (2-CR and 1- NR at 90, 180, 270, 360, 450 days)
An analysis of the Study II clinical data (with 3 patients from Study Ib) provides the following interim assessments: